EPSTEIN-BARR VIRUS INFECTION
Clinical trials for EPSTEIN-BARR VIRUS INFECTION explained in plain language.
Never miss a new study
Get alerted when new EPSTEIN-BARR VIRUS INFECTION trials appear
Sign up with your email to follow new studies for EPSTEIN-BARR VIRUS INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
First human trial for new mono and Cancer-Linked virus vaccines begins
⭐️ VACCINE ⭐️ Recruiting nowThis study is testing the safety of two new experimental vaccines designed to prevent infection with Epstein-Barr virus (EBV), which causes mononucleosis and is linked to certain cancers and autoimmune diseases. Healthy adults aged 18-29, both with and without prior EBV infection…
Matched conditions: EPSTEIN-BARR VIRUS INFECTION
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 03, 2026 21:26 UTC
-
Custom immune cells target dangerous virus in transplant patients
Disease control Recruiting nowThis early-stage study is testing a new cell therapy for patients who develop an Epstein-Barr virus (EBV) infection after a stem cell transplant. Researchers are using specially engineered immune cells designed to find and attack cells infected with the virus. The main goals are …
Matched conditions: EPSTEIN-BARR VIRUS INFECTION
Phase: PHASE1, PHASE2 • Sponsor: Daihong Liu • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC